Johan M. Spoor insider trades
Open-market stock purchases and sales by Johan M. Spoor, Chief Executive Officer at Perspective Therapeutics, Inc, from SEC Form 4 filings since Nov 18, 2011.
Track record: 43% of 7 scored buys are up 5% or more since purchase, averaging +21%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 2, 2026 | CATX Perspective Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- CATX Perspective Therapeutics, Inc: 7 buys, last Mar 2, 2026
- AZRX AzurRx BioPharma, Inc: 1 buy, last Apr 6, 2020
- MTST MetaStat, Inc: 4 buys, last May 18, 2015
- FPMI Fluoropharma Medical, Inc: 6 buys, last Jan 7, 2014
- CEWM Fluoropharma Medical, Inc: other filings, last Sep 25, 2013
- NONE Protea Biosciences Group, Inc: other filings, last Jun 18, 2013
- AHRO.OB AtheroNova Inc: other filings, last Feb 15, 2013